PYXS RSI Chart
Last 7 days
-4.4%
Last 30 days
-14.1%
Last 90 days
-23.8%
Trailing 12 Months
11.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 6.5M | 0 | 0 | 0 |
2023 | 4.4M | 0 | 6.0M | 6.8M |
2022 | 1.0M | 0 | 1.9M | 2.8M |
2021 | 0 | 0 | 0 | 181.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 26, 2024 | humphrey rachel | acquired | - | - | 38,741 | - |
Mar 26, 2024 | cline darren s | acquired | - | - | 35,219 | - |
Mar 26, 2024 | dupont jakob | acquired | - | - | 38,741 | - |
Mar 26, 2024 | wadhane jitendra | acquired | - | - | 131,484 | svp, chief accounting officer |
Mar 26, 2024 | connealy pamela ann | acquired | - | - | 328,710 | cfo & coo |
Mar 26, 2024 | flavin john l | acquired | - | - | 35,219 | - |
Mar 26, 2024 | lewis-hall freda c | acquired | - | - | 35,219 | - |
Nov 29, 2023 | connealy pamela ann | sold (taxes) | -51,728 | 1.4 | -36,949 | cfo and coo |
Nov 15, 2023 | wadhane jitendra | acquired | - | - | 40,000 | chief accounting officer |
Sep 28, 2023 | connealy pamela ann | bought | 14,960 | 1.87 | 8,000 | cfo and coo |
Which funds bought or sold PYXS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Ikarian Capital, LLC | new | - | 7,081,860 | 7,081,860 | 0.78% |
May 16, 2024 | JANE STREET GROUP, LLC | added | 1,067 | 719,544 | 746,573 | -% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | reduced | -1.99 | 561,018 | 986,169 | 0.02% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | sold off | -100 | -164,813 | - | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 4,292 | 2,459,730 | 2,483,620 | -% |
May 15, 2024 | Point72 Asia (Singapore) Pte. Ltd. | new | - | 127,097 | 127,097 | 0.03% |
May 15, 2024 | Yu Fan | unchanged | - | 170,486 | 295,231 | 0.41% |
May 15, 2024 | Cable Car Capital LLC | unchanged | - | 151,551 | 262,442 | 0.36% |
May 15, 2024 | Deep Track Capital, LP | new | - | 17,824,300 | 17,824,300 | 0.51% |
May 15, 2024 | SUPERSTRING CAPITAL MANAGEMENT LP | new | - | 2,103,410 | 2,103,410 | 1.39% |
Unveiling Pyxis Oncology, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Pyxis Oncology, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Pyxis Oncology, Inc. News
Income Statement (Quarterly) | |||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 |
Revenue | -2.8% | 1,550 | 1,594 | 1,707 | 1,673 | 1,872 | 719 | 585 | 450 | 316 | 181 |
Operating Expenses | -100.0% | - | 25,136 | 25,354 | 6,216 | 49,121 | 28,393 | 9,094 | -24,334 | 11,621 | 5,941 |
S&GA Expenses | -100.0% | - | 9,047 | 10,667 | 3,279 | 8,119 | 9,359 | 1,986 | -2,170 | 3,772 | 2,736 |
R&D Expenses | -19.0% | 13,029 | 16,089 | 14,687 | 2,937 | 36,336 | 19,034 | 7,108 | -22,164 | 7,849 | 3,205 |
Income Taxes | - | - | - | - | 20.00 | - | - | - | - | - | - |
Net Income | 79.1% | -3,256 | -15,597 | -23,049 | -19,243 | -36,101 | -27,674 | -31,380 | 30,230 | -14,175 | -8,146 |
Net Income Margin | 17.8% | -8.86* | -10.78* | -15.79* | -24.86* | -43.67* | -28.58* | -22.52* | -159.76* | - | - |
Free Cashflow | -37.3% | -20,947 | -15,254 | -17,644 | -6,762 | -19,245 | -24,823 | -8,383 | -259 | -7,288 | 2,491 |
Balance Sheet | |||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2020Q4 |
Assets | 26.8% | 220 | 174 | 187 | 175 | 18.00 | 211 | 224 | 243 | 253 | 39.00 | 139 | 10.00 |
Current Assets | 38.3% | 172 | 125 | 139 | 149 | 17.00 | 187 | 203 | 227 | 251 | 38.00 | 134 | 8.00 |
Cash Equivalents | 189.4% | 28.00 | 10.00 | 15.00 | 26.00 | 13.00 | 179 | 199 | 223 | 247 | 23.00 | 133 | 8.00 |
Net PPE | -4.5% | 11.00 | 12.00 | 12.00 | 13.00 | - | 11.00 | 6.00 | 1.00 | 1.00 | 0.00 | 1.00 | 1.00 |
Liabilities | -24.9% | 36.00 | 48.00 | 49.00 | 30.00 | 14.00 | 51.00 | 35.00 | 31.00 | 19.00 | 17.00 | 17.00 | 4.00 |
Current Liabilities | -45.1% | 14.00 | 26.00 | 28.00 | 9.00 | 14.00 | 32.00 | 19.00 | 15.00 | 19.00 | 17.00 | 17.00 | 4.00 |
Shareholder's Equity | 46.5% | 184 | 126 | 138 | 145 | 152 | 161 | 189 | 212 | 234 | 261 | - | 50.00 |
Retained Earnings | -1.1% | -289 | -286 | -270 | -247 | -182 | -212 | -176 | -148 | -123 | -144 | -74.89 | -15.74 |
Additional Paid-In Capital | 15.0% | 474 | 412 | 409 | 393 | 186 | 373 | 365 | 361 | 357 | 167 | 3.00 | 0.00 |
Shares Outstanding | 29.9% | 58.00 | 45.00 | 44.00 | 39.00 | 25.00 | 35.00 | 32.00 | 32.00 | 18.00 | 18.00 | 1.00 | 1.00 |
Float | - | - | - | - | 97.00 | - | - | - | 77.00 | - | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 |
Cashflow From Operations | -35.8% | -20,710 | -15,254 | -17,583 | -31,110 | -6,762 | -17,387 | -20,557 | -43,051 | -8,340 | -745 | -7,288 | 2,862 | -18,731 | - | - |
Share Based Compensation | 34.4% | 4,320 | 3,215 | 5,179 | 8,066 | 486 | 3,898 | 4,449 | 6,996 | 421 | -2,186 | 307 | 572 | 2,450 | - | - |
Cashflow From Investing | -280.9% | -18,498 | 10,228 | 6,571 | -123,798 | 2,150 | -1,858 | -4,266 | -2,795 | 2,520 | 22,614 | - | -371 | -219 | - | - |
Cashflow From Financing | 230144.0% | 57,511 | -25.00 | -171 | 3,585 | 2,540 | - | 6.00 | 249 | -72.00 | -149,107 | -1,708 | -682 | 151,534 | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues | $ 16,146 | |
Costs and operating expenses: | ||
Cost of revenues | 475 | |
Research and development | 13,029 | $ 11,901 |
General and administrative | 8,247 | 9,053 |
Total costs and operating expenses | 21,751 | 20,954 |
Loss from operations | (5,605) | (20,954) |
Other income, net: | ||
Interest and investment income | 1,550 | 1,673 |
Sublease income | 799 | 38 |
Total other income, net | 2,349 | 1,711 |
Net loss | $ (3,256) | $ (19,243) |
Net loss per common share - basic | $ (0.06) | $ (0.54) |
Net loss per common share - diluted | $ (0.06) | $ (0.54) |
Weighted average shares of common stock outstanding - basic | 51,289,284 | 35,351,671 |
Weighted average shares of common stock outstanding - diluted | 51,289,284 | 35,351,671 |
Other comprehensive (loss) income: | ||
Net unrealized (loss) gain on marketable debt securities | $ (123) | $ 696 |
Other comprehensive (loss) income | (123) | 696 |
Comprehensive loss | (3,379) | $ (18,547) |
Royalty Revenues | ||
Revenues | 8,146 | |
Sale of Royalty Rights | ||
Revenues | $ 8,000 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 27,967 | $ 9,664 |
Marketable debt securities, short-term | 129,060 | 109,634 |
Restricted cash | 1,472 | 1,472 |
Accounts receivable | 8,000 | |
Prepaid expenses and other current assets | 5,880 | 3,834 |
Total current assets | 172,379 | 124,604 |
Property and equipment, net | 11,333 | 11,872 |
Intangible assets, net | 23,730 | 24,308 |
Operating lease right-of-use assets | 12,778 | 12,942 |
Total assets | 220,220 | 173,726 |
Current liabilities: | ||
Accounts payable | 2,293 | 3,896 |
Accrued expenses and other current liabilities | 10,828 | 12,971 |
Operating lease liabilities, current portion | 1,020 | 1,232 |
Deferred revenues | 7,660 | |
Total current liabilities | 14,141 | 25,759 |
Operating lease liabilities, net of current portion | 19,759 | 20,099 |
Deferred tax liability, net | 2,164 | 2,164 |
Total liabilities | 36,064 | 48,022 |
Commitments and contingencies (Note 14) | ||
Stockholders' equity: | ||
Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; zero shares issued and outstanding | ||
Common stock, $0.001 par value per share; 190,000,000 shares authorized; 58,803,126 and 44,754,853 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively. | 59 | 45 |
Additional paid-in capital | 473,638 | 411,821 |
Accumulated other comprehensive (loss) income | (60) | 63 |
Accumulated deficit | (289,481) | (286,225) |
Total stockholders' equity | 184,156 | 125,704 |
Total liabilities and stockholders' equity | $ 220,220 | $ 173,726 |